{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Pharmacotherapy Options for Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: a Brief Guide for Clinicians


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Discuss pharmacotherapy for alcohol use disorder, including its indication for treatment of alcohol-associated liver disease.
  2. Identify FDA approved therapies for alcohol use disorder and explain which are indicated for various stages of liver disease, and which are contra-indicated.
Price: $30.00


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: CLD0523A
Published: May 2023
Expires: 5/31/2025
Required Passing Score: 2/3 (66%)
Authors: Christopher Coe, Arpan Patel and David Lawrence
Categories: Hepatology
Specialties: Hepatology